专业监测看板

Docosahexaenoic Acid (DHA) Supplementation in Amblyopia

药物 / 成分：Docosahexaenoic Acid、Placebo Oral Tablet

登记的停止原因（原文）：Hopkins failed to review contract with company providing complimentary dha, support was withdrawn necessitating me to get more grant money to fund study which was unsucccessful.

A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine

药物 / 成分：SCTV01C、Comirnaty

登记的停止原因（原文）：There was not a need to carry out a study in LAO any more.

A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

药物 / 成分：SCTV01C、SCTV01C、SCTV01C、SCTV01E

登记的停止原因（原文）：There was not a need any more.

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015)

药物 / 成分：Tranexamic Acid、Tranexamic Acid、Oxytocin

登记的停止原因（原文）：Authorization denied

Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism

药物 / 成分：Alteplase

Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma.

药物 / 成分：[18F]DPA-714

登记的停止原因（原文）：Organisational difficulties

Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden

药物 / 成分：personalized DC vaccine

登记的停止原因（原文）：No participants enrolled

The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus

药物 / 成分：Ketamine

登记的停止原因（原文）：Unable to enroll patients

Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.

药物 / 成分：Insulin、Tarsorrhaphy

登记的停止原因（原文）：Study never commenced due to logistical issues.

Vortioxetine for the Treatment of Hoarding Disorder

药物 / 成分：Vortioxetine Tablets

登记的停止原因（原文）：COVID-19 pandemic

Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

药物 / 成分：Placebo、Psilocybin

登记的停止原因（原文）：Lack of funding

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

药物 / 成分：Cytoreductive surgery、LMB-100、Immunohistochemical Assay for Mesothelin

登记的停止原因（原文）：No participants enrolled.

Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype

药物 / 成分：Palbociclib 125Mg Tab、Ribociclib 200Mg Oral Tablet、Abemaciclib 150 MG Oral Tablet

登记的停止原因（原文）：funding was not secured

Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients

药物 / 成分：Minocycline Group、Placebo Group

登记的停止原因（原文）：This study was never started and no participants were enrolled.

IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US

药物 / 成分：Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) 320 μg/18 μg/9.6 μg administered as two inhalations, twice daily.、External Comparator

登记的停止原因（原文）：Recruitment challenges

The Avastin vs Visudyne for Neovascular AMD Study

药物 / 成分：Bevacizumab (Avastin)、Verteporfin photodynamic therapy (PDT)

登记的停止原因（原文）：Lucentis, a treatment superior to PDT, has become available i Sweden.

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

药物 / 成分：Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10、Melphalan、Peripheral Blood Stem Cell Transplantation

登记的停止原因（原文）：NIH terminated funding. Study was closed before any participants were enrolled.

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

药物 / 成分：3D011-08

登记的停止原因（原文）：Company's decision

Prevention of Postpartum Hemorrhage With TXA

药物 / 成分：Tranexamic Acid 1000 mg/10ml normal saline infusion

登记的停止原因（原文）：PI retired from Navy 2018

Surgery of Melanoma Metastases After Systemic Therapy

药物 / 成分：Surgical metastasectomy、Immunotherapy

登记的停止原因（原文）：Not possible to recruit patients during COVID, and not possible to start enrolling after the pandemic.